Short description
Aniluxx Biotechnology is a development stage biopharmaceutical company
Description
Aniluxx Biotechnology is a development stage biopharmaceutical company with a mission to improve companion animal health and well-being. The Company’s strategy is to translate its deep pipeline of topically formulated therapeutics, predicated on compounds that have already been identified as safe and effective in humans, into therapies for dogs, cats, and horses, that are easy to apply, virtually unnoticeable, and absent the harsh side effects of systemic medicines.
Total funding
$$2020202
Sign in for full access
Location
Raleigh, North Carolina, United States, North America
Founded on
January 1, 2014
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Nopepepe, Blurry Noaccess
Sign in for full access
Founders
Stefan Weiss